Dachaigh › Ailseachadh an Ae (Carcinoma Hepatocellular) › Arizona
Sgrùdaidhean clionaigeach Ailseachadh an Ae (Carcinoma Hepatocellular) ann an Arizona
Tha 17 sgrùdaidhean airson Ailseachadh an Ae (Carcinoma Hepatocellular) a’ lorg phàirtichean aig làraichean ann an Arizona.
Bailtean ann an Arizona
Teacsa sgrùdaidh oifigeil (Beurla)
A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Arizona, Phoenix
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #67, Phoenix
- Exelixis Clinical Site #1, Tucson
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05176483Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
- Research Facility, Phoenix
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06726161GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- University of Arizona Cancer Center, Tucson
A’ fastadhÌre 1 tràth
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07627191A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- City of Hope Phoenix Cancer Center, Goodyear
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06427941Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Phoenix
- Research Site, Tucson
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06921785A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- HonorHealth Research Institute, Scottsdale
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07636785FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05919264Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Mayo Clinic in Arizona, Scottsdale
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05168163A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Phoenix
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Southern Arizona VA Health Care System, Tucson, AZ, Tucson
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05486572Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Arizona, Phoenix
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT06349642Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Scottsdale Medical Imaging, LLC, Scottsdale
A’ fastadhÌre 4
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 22 Faoi 2026 · NCT04373564A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Samh 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Arizona, Scottsdale
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Samh 2024 · NCT05824975Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Gearr 2024 · NCT04282044Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.